CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age65+
SponsorRigshospitalet, Denmark

About this trial

The objective of this observational, prospective study is to determine the prevalence of Cardiac Amyloidosis (CA) in males over the age of 65 who experience chest pain but show no signs of coronary artery disease (CAD).

Prior to inclusion, all patients will have undergone a CT coronary angiogram or an Rb-PET scan to rule out the possibility of CAD.

Participants will be subject to several examinations, including blood tests, urine samples, ECG, echocardiography, and bone scintigraphy. An endomyocardial biopsy may be conducted if necessary.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Screening thourgh examinations including bonescintigraphy

Treatment groups

300 Participants
are divided into 1 treatment group

Sponsors and collaborators